Saturday November 21 2009 | Biotechnology feed | All feeds
|
|
BIOTECON Therapeutics
Download detailed PDF Members: BIOTECON Therapeutics is engaged in the development of pharmaceutical preparations based on the various serotypes of botulinum toxin. These toxins, produced by the bacterium Clostridium botulinum, are the cause of botulism, which is acquired in most cases by food poisoning and leads to a potentially fatal flaccid paralysis of striated muscles. During the last decade botulinum toxins have attracted increasing interest as potent pharmaceuticals for the treatment of dystonias, spasms, hyperhydrosis and several other disorders connected with muscle hyperfunction.
This page has been viewed 545 times since April 2007, the link to the organisation's website has been followed 106 times Recent Search Terms used to find this page: BIOTECON Therapeutics GmbH | Biotecon Therapeutics | Biotecon therapeutics | Biotecon | biotecon | biotecon therapeutics gmbh | biotecon therapeutics | BIOTECON Therapeutics botulinum | BIOTECON Therapeutics botulinum | Biotecon Therapeutics | . Search for more companies in Potsdam This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for BIOTECON Therapeutics | ||||||||||||||||||||||||||
|